QUAD SHOT radiotherapy for palliation in advanced cancer: current status and future directions

QUAD SHOT radiotherapy (QS-RT) is a periodic, short-course, hypo-fractionated radiotherapy regimen that originated in the 1980s. It is widely used in Europe and the United States, but less so in Asia. Many clinical studies have shown that QS-RT offers significant advantages in improving quality of life and local control and has a favorable safety profile. This article systematically reviews the origin, biological mechanisms, clinical applications, efficacy, and safety of QS-RT based on existing clinical studies, discusses its clinical advantages and limitations, and considers how to optimize future treatment plans.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-04-15
DOI
https://doi.org/10.3389/fonc.2026.1776799
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

QUAD SHOT radiotherapy for palliation in advanced cancer: current status and future directions

Zhaofeng Ning, De-bo Huang, Zheng-Yun Du, Xia Liu et al.
Frontiers in Oncology
Hepatocellular Carcinoma Treatment and Prognosis
article

QUAD SHOT radiotherapy for palliation in advanced cancer: current status and future directions

Zhaofeng Ning, De-bo Huang, Zheng-Yun Du, Xia Liu, Jian-Liang Liu, Yun-Long Hu
article en

Abstract

QUAD SHOT radiotherapy (QS-RT) is a periodic, short-course, hypo-fractionated radiotherapy regimen that originated in the 1980s. It is widely used in Europe and the United States, but less so in Asia. Many clinical studies have shown that QS-RT offers significant advantages in improving quality of life and local control and has a favorable safety profile. This article systematically reviews the origin, biological mechanisms, clinical applications, efficacy, and safety of QS-RT based on existing clinical studies, discusses its clinical advantages and limitations, and considers how to optimize future treatment plans.

Frontiers in OncologyVol. 16
Shanxi Provincial Cancer Hospital (CN)
Openalex Percentile: Top 32%
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.